Sava Infond
JAZZ icon

Sava Infond’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sava Infond’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$972K Hold
4,200
– – 0.06% 114
2026
Q2 		$1.01M Hold
4,200
– – 0.07% 106
2026
Q1 		$794K Hold
4,200
– – 0.11% 113
2025
Q4 		$714K Hold
4,200
– – 0.1% 117
2025
Q3 		$554K Hold
4,200
– – 0.08% 122
2025
Q2 		$446K Buy
4,200
+780
+23% +$84.7K 0.07% 125
2025
Q1 		$425K Hold
3,420
– – 0.08% 126
2024
Q4 		$421K Buy
+3,420
New +$403K 0.07% 124

Other funds holding JAZZ

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Argent Capital Management
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.9B AUM 30.31% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Sava Infond's JAZZ Position: Q3 2026 in Review

Sava Infond held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2026 at 4,200 shares worth $972K. The position accounts for 0.06% of the portfolio, ranked #114.

Sava Infond first reported a position in JAZZ in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.01M in Q2 2026. 279 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Sava Infond held 4,200 shares of Jazz Pharmaceuticals worth $972K as of Q3 2026.
  • Sava Infond left its Jazz Pharmaceuticals share count unchanged in Q3 2026.
  • Jazz Pharmaceuticals made up 0.06% of Sava Infond's portfolio in Q3 2026, its #114 holding.
  • Sava Infond first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • Sava Infond's Jazz Pharmaceuticals position peaked at $1.01M in Q2 2026.
  • 279 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Sava Infond's 13F filing for Q3 2026, filed 28 Oct 2026.